Abstract
Rationale: Women with BRCA gene mutations have a high risk of developing breast cancer. The Mediterranean Diet (MedD) is associated with a reduced risk of various cancer entities, including breast cancer, proposedly due to high dietary intake of omega-3 (n-3) and n-9 fatty acids (FA), combined with low intake of n-6 FA. The LIBRE study, a randomized multicenter trial including 660 women, examines potential effects of lifestyle modifications, including a MedD, in women with high genetic cancer risk. Here we aim to determine biological parameters that conceivably reflect adherence to the MedD, such as red blood cell membrane (RBCM) FA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
